News
-
-
COMMUNIQUÉ DE PRESSE
Evotec Announces New Nomination to Board of Directors
Evotec SE announces the nomination of Dr. Wolfgang Hofmann as independent member of the Supervisory Board, strengthening oversight and governance. Cooperation agreement with MAK Capital enhances shareholder dialogue and long-term value creation -
-
-
COMMUNIQUÉ DE PRESSE
Evotec SE to Announce First Quarter 2026 Results on May 6, 2026
Evotec SE to announce First Quarter 2026 Results on May 6, 2026 in a webcast and conference call. Details for participation provided. Evotec is a leading life science company focused on drug discovery and development -
-
-
-
-